TD Cowen Maintains Hold on Ocular Therapeutix, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Tara Bancroft has maintained a Hold rating on Ocular Therapeutix (NASDAQ:OCUL) but lowered the price target from $11 to $7.

May 08, 2024 | 4:58 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TD Cowen maintains a Hold rating on Ocular Therapeutix but lowers the price target from $11 to $7.
The reduction in price target by TD Cowen suggests a bearish outlook on the stock's short-term price potential, likely due to underlying challenges or revised expectations. This could lead to negative investor sentiment and a potential decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100